MARKET

ASXC

ASXC

Asensus Surgical Inc
AMEX

Real-time Quotes | Nasdaq Last Sale

1.950
-0.010
-0.51%
After Hours: 1.950 0 0.00% 19:43 09/16 EDT
OPEN
1.910
PREV CLOSE
1.960
HIGH
1.980
LOW
1.900
VOLUME
2.77M
TURNOVER
--
52 WEEK HIGH
6.95
52 WEEK LOW
0.3201
MARKET CAP
456.93M
P/E (TTM)
-4.5529
1D
5D
1M
3M
1Y
5Y
Asensus Surgical, Inc. to Participate in Three Upcoming Virtual Healthcare Conferences
RESEARCH TRIANGLE PARK, N.C., September 08, 2021--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will p...
Business Wire · 09/08 10:55
BRIEF-Asensus Surgical Receives FDA 510(K) Clearance For Expansion Of Machine Vision Capabilities
reuters.com · 09/01 12:39
Asensus Surgical Receives FDA 510(k) Clearance for Expansion of Machine Vision Capabilities
RESEARCH TRIANGLE PARK, N.C., September 01, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced t...
Business Wire · 09/01 12:00
Asensus Gets FDA Clearance for Expansion of Surgical Platform's Machine Vision Capabilities
MT Newswires · 09/01 10:20
Mid-Morning Market Update: Markets Open Lower; Walmart Profit Tops Estimates
Following the market opening Tuesday, the Dow traded down 0.67% to 35,385.44 while the NASDAQ fell 0.79% to 14,676.74. The S&P also fell, dropping 0.54% to 4,455.32.
Benzinga · 08/17 14:32
55 Stocks Moving In Friday's Mid-Day Session
Gainers
Benzinga · 08/06 16:00
Expedia Group, Novavax, Zynga among premarket losers' pack
Spectrum Pharmaceuticals SPPI -35% after FDA declines to approve ROLONTIS Dicerna Pharmaceuticals DRNA -28% slide despite pivotal nedosiran study hitting primary endpoint Zynga ZNGA -16% on Q2 earnings release Chembio Diagnostics CEMI -13% on Q2 earnings r...
Seekingalpha · 08/06 12:43
Asensus Surgical (ASXC) Reports Q2 Loss, Misses Revenue Estimates
Zacks.com · 08/05 23:15
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ASXC. Analyze the recent business situations of Asensus Surgical Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ASXC stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 157
Institutional Holdings: 73.36M
% Owned: 31.31%
Shares Outstanding: 234.32M
TypeInstitutionsShares
Increased
45
6.91M
New
19
2.21M
Decreased
31
11.32M
Sold Out
24
1.40M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.13%
Healthcare Equipment & Supplies
-0.15%
Key Executives
Non-Executive Chairman/Independent Director
Paul LaViolette
President/Chief Executive Officer/Director
Anthony Fernando
Chief Financial Officer/Executive Vice President
Shameze Rampertab
Independent Director
Andrea Biffi
Independent Director
Kevin Hobert
Independent Director
Jane Hsiao
Independent Director
Elizabeth Kwo
Independent Director
David Milne
Independent Director
Richard Pfenniger
Independent Director
William Starling
No Data
  • All
  • Financials
  • Insiders
More
About ASXC
Asensus Surgical, Inc., formerly TransEnterix, Inc., is a medical device company. The Company is engaged in digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through digital laparoscopy. The Senhance system is a machine vision system for use in robotic surgery, which is powered by intelligent surgical unit that enables augmented intelligence in surgery. Its System is designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, advanced instrumentation, including three-millimeter micro laparoscopic instruments, eye-sensing camera control and reusable standard instruments to patients around the world. The Senhance System is used in Europe for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.

Webull offers kinds of Asensus Surgical Inc stock information, including AMEX:ASXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASXC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ASXC stock methods without spending real money on the virtual paper trading platform.